Ezinsukwini zakamuva , amaklayenti ayanda abuza i-semaglutide , kuyini ?
ake sibone -
I-Semaglutide umuthi we-antidiabetic osetshenziselwa ukwelashwa kwesifo sikashukela sohlobo 2 kanye nemithi elwa nokukhuluphala esetshenziselwa ukuphathwa kwesisindo eside.Iyi-peptide efana ne-hormone glucagon-like peptide-1 (GLP-1), eguquliwe iketango elisemaceleni.
Ingalawulwa ngomjovo we-subcutaneous noma ithathwe ngomlomo.
Ithengiswa ngaphansi kwamagama e-brand Ozempic kanye ne-Rybelsus yesifo sikashukela, futhi ngaphansi kwegama lomkhiqizo elithi Wegovy lokunciphisa umzimba.
bunjani ubumsulwa ?
umbiko wokuhlola ubonisa, kuphakeme kakhulu prutiy 99.26% ,
Ukusetshenziswa kwezokwelapha
I-Semaglutide iboniswa njenge-adjunct yokudla nokuzivocavoca ukuthuthukisa ukulawulwa kwe-glycemic kubantu abadala abanesifo sikashukela sohlobo lwe-2.
Ukwakhiwa kwe-dose ephakeme ye-semaglutide kuboniswa njenge-adjunct yokudla nokuzivocavoca kokuphathwa kwesisindo eside kubantu abadala abanokukhuluphala (i-intial body mass index (BMI) ≥ 30 kg / m2) noma abakhuluphele (i-BMI yokuqala ≥ 27 kg /m2) futhi okungenani abe ne-commorbidity eyodwa ehlobene nesisindo.
Imiphumela emibi
I-Semaglutide i-gcagon-like peptide-1 receptor agonist.
Imiphumela emibi evame kakhulu ihlanganisa isicanucanu, ukuhlanza, isifo sohudo, ubuhlungu besisu, nokuqunjelwa.
umkhiqizo ofanayo
i-semaglutide
I-Tirzepatide
isitifiketi
I-Retatrutid
I-Liraglutide
uma ufuna imininingwane eyengeziwe ngicela ungazise
Isikhathi sokuthumela: May-22-2024